{
    "Trade/Device Name(s)": [
        "InstaStrip Fentanyl Rapid Test (Urine)",
        "InstaStrip Fentanyl Dipstick Test (Urine)"
    ],
    "Submitter Information": "Instanosis Inc.",
    "510(k) Number": "K240295",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233417"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL"
    ],
    "Summary Letter Date": "January 24, 2024",
    "Summary Letter Received Date": "February 1, 2024",
    "Submission Date": "March 25, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Lateral flow",
        "Immunochromatographic assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Immunochemistry"
    ],
    "Submission Type(s)": [
        "Test",
        "Dipstick"
    ],
    "Document Summary": "FDA 510(k) summary for InstaStrip Fentanyl Rapid Test and Dipstick Test (Urine), an OTC immunoassay for qualitative detection of fentanyl in urine.",
    "Indications for Use Summary": "Intended for the qualitative detection of fentanyl in human urine at a cutoff value of 1.0 ng/mL; provides preliminary analytical results and is for over-the-counter use.",
    "fda_folder": "Toxicology"
}